ISS microgravity drives unique phage–bacteria mutations, yielding improved therapeutic viruses
Experiments aboard the International Space Station reveal bacteriophages and their E. coli hosts acquire mutation patterns in microgravity that differ from Earth-based evolution. Some space-evolved phage variants demonstrated enhanced ability to infect and kill bacteria, and were used to generate improved therapeutic viruses targeting drug‑resistant infections.
Discovered |
